Pillsbury today welcomed new corporate partner Steven M. Tyndall. With a broad client base ranging from formation stage and emerging companies to established public and private companies, Tyndall focuses on advising clients in the areas of technology, life sciences and clean energy.

“We are very pleased to welcome Steve to Pillsbury,” said Firm Chair Jim Rishwain Jr. “His deep industry knowledge and experience will be of great benefit to our clients in Texas and around the world. With our global platform and the recent addition of Andrew Strong, former CEO of Kalon Biotherapeutics, we are poised to further build on our recognized position as a worldwide leader in the life sciences industry.” (more…)

www.pillsburylaw.com